Erika L. Eves
2022
In 2022, Erika L. Eves earned a total compensation of $223.4K as Vice President, Finance & Administration at Navidea Biopharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $26,250 |
|---|---|
| Salary | $181,667 |
| Stock Awards | $1,680 |
| Other | $13,817 |
| Total | $223,414 |
Eves received $181.7K in salary, accounting for 81% of the total pay in 2022.
Eves also received $26.3K in non-equity incentive plan, $1.7K in stock awards and $13.8K in other compensation.
Rankings
In 2022, Erika L. Eves' compensation ranked 5,030th out of 5,387 executives tracked by ExecPay. In other words, Eves earned more than 6.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,030 out of 5,387 | 7th |
Division Manufacturing | 2,753 out of 2,922 | 6th |
Major group Chemicals And Allied Products | 1,257 out of 1,304 | 4th |
Industry group Drugs | 1,172 out of 1,209 | 3rd |
Industry In Vitro and In Vivo Diagnostic Substances | 24 out of 25 | 4th |
Source: SEC filing on October 5, 2023.
Eves' colleagues
We found one more compensation record of an executive who worked with Erika L. Eves at Navidea Biopharmaceuticals in 2022.
2022
Michael Rosol
Navidea Biopharmaceuticals